Nuveen Asset Management, LLC Vincerx Pharma, Inc. Transaction History

Nuveen Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.0 - $0.0 $0 - $0	-40,474 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.0 - $0.0 $0 - $0	-39,051 Reduced 49.11%	40,474 $173,000
Q4 2021 Feb 14, 2022	BUY	$0.0 - $0.0 $0 - $0	7,183 Added 9.93%	79,525 $746,000
Q3 2021 Nov 12, 2021	BUY	$0.0 - $0.0 $0 - $0	72,342 New	72,342 $1.14 Million

11M

Ticker VINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,189,800
Market Cap $6.57M
Description
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.